Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2010
11/10/2010EP2247596A2 Novel pyrazolo [3, 4 -d] pyrimidine derivatives as anti -cancer agents
11/10/2010EP2247595A1 Pyrrolopyrazine kinase inhibitors
11/10/2010EP2247594A1 Pyrrolopyrimidinecarboxamides
11/10/2010EP2247593A1 Pyrrolopyrazine kinase inhibitors
11/10/2010EP2247592A1 Pyrrolopyrazine kinase inhibitors
11/10/2010EP2247591A1 Pyrrolo [2, 3-d]pyridines and use thereof as tyrosine kinase inhibitors
11/10/2010EP2247590A1 Pyrazolopyrimidines, a process for their preparation and their use as medicine
11/10/2010EP2247589A1 7-azaindole derivatives as selective 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors
11/10/2010EP2247588A2 Fused heterocyclic derivative and use thereof
11/10/2010EP2247587A1 5-oxo-2, 3,4,5-tetrahydro-benzo[b]oxepine-4-carboxylic acid amides and 2,3-dihydro-benzo[b]oxepine-4-carboxylic acid amides for treatment and prevention of diabetes typ 1 and 2
11/10/2010EP2247586A1 2-aza-bicyclo[2.2.1]heptane derivatives
11/10/2010EP2247585A1 Crystal forms of n-ý2-(diethylamino)ethyl¨-5-ý(5-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene)methyl¨-2,4-dimethyl-1h-pyrrole-3-carboxamide and methods for their preparation
11/10/2010EP2247584A1 Fused pyridines active as inhibitors of c-met
11/10/2010EP2247583A1 Hydrazines in glaucoma therapy
11/10/2010EP2247580A1 Quinoxalinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes
11/10/2010EP2247579A1 Sulphoximine-substituted quinazoline derivatives as immunomodulators, their preparation and use as medicaments
11/10/2010EP2247578A1 Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors
11/10/2010EP2247575A2 Cyclic indole-3-carboxamides, their preparation and their use as pharmaceuticals
11/10/2010EP2247571A2 Derivatives of aminoalkanols, method of obtaining of aminoalkanols and their use
11/10/2010EP2247570A1 Novel salts of o-desmethyl-venlafaxine
11/10/2010EP2247569A1 Acid salt of tolterodine having effective stability for transdermal drug delivery system
11/10/2010EP2247563A1 13,13-dimethyl-des-c,d analogs of 1alpha, 25-dihydroxy-19-nor-vitamin d3 compounds and topical composition dosage forms and methods of treating skin conditions thereof
11/10/2010EP2247294A2 Macrolides for treating diseases mediated through pde inhibition
11/10/2010EP2247293A2 Novel compositions and methods for treatment of diseases related to activated lymphocytes
11/10/2010EP2247292A1 Pyridopyrazinones derivatives insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes
11/10/2010EP2247291A1 Methods and compositions for treating inflammatory bowel disease
11/10/2010EP2247290A1 Polyphenols for the treatment of cartilage disorders
11/10/2010EP2247289A2 Ophthalmic nsaids as adjuvants
11/10/2010EP2247288A1 Use of hedgehog agonists in the treatment of musculoskeletal-related disorders
11/10/2010EP2247287A2 Method for the identification of patients in need of therapy having minor cognitive disorders and the treatment of such patients
11/10/2010EP2247286A2 Alcohol antimicrobial skin sanitizing compositions including cationic compatible thickeners
11/10/2010EP2247284A2 Process to minimize polymorphism
11/10/2010EP2247283A2 Micronized opioid compositions, formulations and dosage forms and methods of making same
11/10/2010EP2247258A1 Rescue of photoreceptors by intravitreal administation of an expression vector encoding a therapeutic protein
11/10/2010EP2247201A2 Food products containing omega-3 fatty acids
11/10/2010EP2247199A1 Methods and compositions for the treatment of bone conditions
11/10/2010EP2247196A2 Sweetener compositions and methods of making them
11/10/2010EP2247185A2 Tyrosine kinase inhibitors
11/10/2010EP2247183A1 Methods and compositions for inhibiting progression to chronic cardiac failure
11/10/2010EP2146997B1 Substituted furo[2,3-b]pyridine derivatives as cannabinoid-1 receptor modulators
11/10/2010EP2146946B1 (-)- stereoisomer of 2,6-di-sec-butylphenol and analogs thereof
11/10/2010EP2120968B1 Use of d-ribose to treat atrial fibrillations
11/10/2010EP2114888B1 Tricyclic compounds and their use as glucocorticoid receptor modulators
11/10/2010EP2111403B1 Triazabenzo[e]azulene derivatives for the treatment of tumors
11/10/2010EP2109612B1 5,6,7,8-tetrahydropteridine derivatives as hsp90 inhibitors
11/10/2010EP2029549B1 Phenyl-pyrazole derivatives as non-steroidal glucocoricoid receptor ligands
11/10/2010EP2018169B1 Use of 4,17 beta-dihydroxyandrost-4-ene-3-one for treating cancers
11/10/2010EP1995249B1 Camptothecin derivatives and their use
11/10/2010EP1966226B1 Azacytosine derivatives useful as antiviral agents
11/10/2010EP1957492B1 Substituted bicyclic pyrimidone derivatives
11/10/2010EP1940407B1 N-(4-oxo-3,4-dihydroquinazolin-2-yl)butanamides as androgen receptor modulators
11/10/2010EP1937659B1 Cyclic n-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals
11/10/2010EP1919908B1 Triazole derivatives as modulators of dopamine d3 receptors
11/10/2010EP1912991B1 Xanthine derivatives as selective hm74a agonists
11/10/2010EP1910316B1 Substituted triazole derivatives and their use as neurokinin 3 receptor antagonists
11/10/2010EP1896445B1 ( 6-FLU0R0-BENZ0[l, 3] DIOXOLYL) -MORPHOLIN-4-YL-METHANONES AND THEIR USE AS CBl LIGANDS
11/10/2010EP1888582B1 Imidazo- and triazolopyridines as inhibitors of 11-beta hydroxysteroid dehydrogenase type i
11/10/2010EP1877365B1 Acetylene derivatives
11/10/2010EP1874764B1 Imino-oxazolidines and use thereof as anticoagulants
11/10/2010EP1869056B1 Novel 5-substituted 7-amino-ý1,3¨thiazoloý4,5-d¨pyrimidine derivatives
11/10/2010EP1869024B1 New tricyclic angiotensin ii agonists
11/10/2010EP1833840B9 Potent lna oligonucleotides for the inhibition of hif-1a
11/10/2010EP1799227B1 Therapeutic agents targeting the nc ca-atp channel and methods of use thereof
11/10/2010EP1742944B1 Indoles, 1h-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof
11/10/2010EP1732551B1 Perhexilin for treating chronic heart failure
11/10/2010EP1723104B1 Sulfur-containing compositions and processes for making same
11/10/2010EP1711056B1 Antimicrobial compositions comprising polymeric stabilizers
11/10/2010EP1653944B1 Heterocyclic compounds useful as malonyl-coa decarboxylase inhibitors
11/10/2010EP1651677B1 Heparin-derived oligosaccharide mixtures, preparation thereof and pharmaceutical compositions containing said mixtures
11/10/2010EP1643997B1 Flupirtine preparation for treating neurodegenerative disorders of the visual system and diabetes mellitus
11/10/2010EP1637517B1 2-aminobicyclo 3.1.0 hexane-2,6-dicarboxylic ester derivative
11/10/2010EP1633340B1 Compounds for the treatment of metabolic disorders
11/10/2010EP1618113B1 Novel crystalline polymorphs of clopidogrel
11/10/2010EP1603595B1 Pharmaceutical composition for treatment of drug dependence
11/10/2010EP1589966B1 Preparation of new pharmaceutically suitable salt of losartan and forms thereof with new purification and isolation methods
11/10/2010EP1569692B1 Betaine and salicylic acid compositions
11/10/2010EP1567166B1 Superoxide dismutase mimics for the treatment of ocular disorders and diseases
11/10/2010EP1553927B1 Gel-stabilized nanoparticulate active agent compositions
11/10/2010EP1545525B1 Radiolabeled neurokinin-1 receptor antagonists
11/10/2010EP1513589B1 1,5-disubstituted pyrrolid-2-one derivatives for use as ep4 receptor agonists in the treatment of eye diseases such as glaucoma
11/10/2010EP1460995B1 Transdermal transport of compounds
11/10/2010EP1454950B1 Pullulan-containing powder, process for producing the same and use thereof
11/10/2010EP1411951B2 Enteral compositions for the prevention and/or treatment of sepsis
11/10/2010EP1401433B1 Azole acid derivatives, alone or in combination, for treating diabetes and dyslipidemias; and for treating malignant diseases
11/10/2010EP1181274B1 Iminocyclitol inhibitors of hexoaminidase and glycosidase
11/10/2010EP1153613B1 Percutaneous absorption preparations of compound having angiotensin ii receptor antagonism
11/10/2010EP1089748B2 Water-soluble native dry ginkgo biloba extract with a high terpenoid and flavone glycoside content
11/10/2010EP1039882B1 Therapeutic formulation for administering tolterodine with controlled release
11/10/2010CN201625211U Tablet capsule filled with Dihydroergocryptine mesylate A tablet and caffeine tablet
11/10/2010CN201625210U Tablet capsule filled with Dutasteride tablet and Tamsulosin tablet
11/10/2010CN1994352B Use of total glucosides extract of cocklebur fruit in preparation of product for resisting inflammatory reaction
11/10/2010CN1993133B Apiary veterinary composition
11/10/2010CN1989129B A crystalline variable hydrate of (s)-6-(4-(2-((3-(9h-carbazol-4-yloxy)-2-hydroxypropyl)amino)-2-methylpropyl)phenoxy)-3-pyridinicarbox amide hemisuccinate salt
11/10/2010CN1984900B Indole derivatives having piperidine rings
11/10/2010CN1980889B Adamantyl pyrrolidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
11/10/2010CN1973902B Anticancer medicine adriamycin composition with ginseng polyse as carrier and its preparation process
11/10/2010CN1965839B Sustained release microsphere of finasteride and its analogue, preparation process and use thereof
11/10/2010CN1950104B Medicament for the treatment of fungal infections, particularly aspergillosis
11/10/2010CN1946693B Therapeutic formulations of desoxyepothilones
11/10/2010CN1943620B Chinese medicine composition for treating cardio-cerabral vascular diseases and its preparing method
1 ... 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 ... 7860